mRNA RSV Vaccine Trial | 60+ Years Old | $490

Los Angeles CA

Description

Did you know that there is currently no vaccine for Respiratory Syncytial Virus (RSV), and that RSV cases are already surging this year? Fortunately, Velocity Clinical Research and other sites around the world are studying an RSV vaccine utilizing the same mRNA technology that helped develop COVID vaccines in a short time. There is an urgent need to enroll patients into this critical clinical study to protect older adults from the growing RSV threat. If you are 60-years-old or older, you can enroll today. Interested volunteers should sign up here or call us as soon as possible at (818) 558-7555. Study details: Compensation of at least $490 for completing all study visits One shot of either vaccine or placebo per year for two years Seven (7) total visits in-person and over the phone over two years The staff at the research study site will be able to answer any questions. Please contact Erika at Providence Clinical Research at (818) 558-7555 for more information or to participate.